AML

Allogeneic hematopoietic stem cell transplantation (HSCT) is considered standard of care in eligible patients with acute myeloid leukemia (AML) and intermediate or adverse risk in first complete remission (CR) as …

Russell NH, Hills RK, Thomas A, Thomas I, Kjeldsen L, Dennis M, et al. Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic …

SAN DIEGO — Bone marrow transplants can save lives for patients with acute myeloid leukemia, but researchers are learning how socioeconomic factors create barriers to treatment and increase mortality rates …

Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. …